:

Robert Connor Chick1, Samantha M Ruff1,2, Julia Monasterio3

  • 1Division of Surgical Oncology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.

PubMed
概括

肝动脉输液 (HAIP) 治疗无法切除的肝脏瘤显示了可接受的安全性和可比的生存结果. 同时切除瘤与较差的整体存活率有关,需要进一步研究.